Shintaro Sengoku
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Strategic manufacturing and versatile applications to expand the mRNA therapeutic frontier.
Journal: Drug discovery today
Published: May 09, 2026
Programmed Medical Device (SaMD) and Orphan Drug Innovation Processes and Industrial Systems
Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
Published: January 04, 2026
Evolution of the division of labor for First-in-Class Drugs: A Quantitative Analysis of Trends across Company Types, Modalities, and Therapeutic Areas (2012-2024).
Journal: Drug discovery today
Published: December 23, 2025
Strategic pathways of digital health platforms in regulated markets: Evidence from wearable devices.
Strategic pathways of digital health platforms in regulated markets: Evidence from wearable devices.
Journal: Digital health
Published: December 15, 2025
Advancing ex vivo gene therapy: the role of lentiviral vectors and organizational collaboration.
Journal: Drug discovery today
Published: May 06, 2025
The Co-Evolution of Markets and Regulation in the Japanese Functional Food Industry: Balancing Risk and Benefit.
Journal: Foods (Basel, Switzerland)
Published: March 29, 2025
Leveraging mHealth wearables for managing patients with Alzheimer's disease: a scoping review.
Journal: Drug discovery today
Published: October 30, 2024
Multi-layer platform coordination for open innovation in oligonucleotide therapeutics.
Journal: Drug discovery today
Published: October 20, 2024
Evolving Research and Development Landscape for Rare Diseases: Growing Concerns Over Orphan Drug Lag in Japan.
Journal: Clinical pharmacology and therapeutics
Published: October 03, 2024
Driving Innovation Through Regulatory Design and Corporate Behaviour: A Case Study of Functional Food Industry in Japan.
Journal: Foods (Basel, Switzerland)
Published: September 17, 2024
Open Innovation and Regulatory Challenges in New Modality Development: The Pivotal Role of Contract Development and Manufacturing Organisations in Advancing Antibody Drugs.
Journal: Therapeutic innovation & regulatory science
Published: March 23, 2024
Cost-effectiveness comparison between blood biomarkers and conventional tests in Alzheimer's disease diagnosis.
Journal: Drug discovery today
Published: November 15, 2023
Last Updated: 09/26/2026